Employers aren't expanding coverage of GLP-1 obesity drugs — many are finding ways around it

11 hours ago

Jim Cramer says these are the 5 stocks to buy during this market rotation

2 days ago

Ebola outbreak harder to contain after USAID, Western aid cuts, experts say

2 days ago

Jim Cramer says this former Covid market darling is finally investable again

7 days ago

Walmart, CVS step in to help seniors with Medicare coverage of obesity drugs

7 days ago

FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes

8 days ago

Cramer says this aerospace stock is significantly undervalued, sees 35% upside

8 days ago

Medicare will start covering obesity drugs. Here's what patients should know

8 days ago

French biotech stock soars 40% after new data on experimental medicine

8 days ago

FDA names first companies chosen for faster review of new manufacturing plants

8 days ago

Medicare is about to cover obesity drugs — but many seniors may not know it yet

10 days ago

Estrogen patches are hard to find, and it may not be resolved any time soon

12 days ago

Chan Zuckerberg Initiative's Biohub to open new rare disease funding round

13 days ago

This life sciences stock has a secret weapon, and AI will only make it more valuable

14 days ago

Extreme heat grips Europe as red alerts issued in UK, France, Spain and Italy

14 days ago

UPS to invest $48 million in cold facilities amid GLP-1 boom

15 days ago

SNAP restrictions could change what shoppers buy — and food giants are watching

18 days ago

U.S. opens tariff probe targeting Germany's drug pricing policies

19 days ago

What this biotech's volatile stock price tells you about the weight loss market right now

19 days ago

UniQure to seek FDA approval for Huntington's disease gene therapy in reversal

20 days ago

Biotech IPO revival faces competition from cash-rich big pharma buyers

22 days ago

Centene to offer buyouts to some employees as health insurer cuts costs

23 days ago

Drugmakers race to find a place in the next wave of obesity drugs

25 days ago

CVS Health executives on reducing healthcare's biggest pain points

25 days ago

Rollins called screwworm a 'little pest' amid U.S. spread. Last year, she called it 'terrifying'

27 days ago

How screwworm in U.S. cattle herds could re-inflate record beef prices

28 days ago

The space race is coming for pharma: Why drug development is heading to orbit

28 days ago

Nuvalent shares surge 39% after GSK agrees to buy drugmaker for $10.6 billion

29 days ago

Jim Cramer says he can't sell Eli Lilly despite its massive run up. Here's why

1 month ago

GLP-1 pioneers Novo and Lilly compete on pills, prepare to pitch seniors

1 month ago

Food supply 'not at risk' after new Texas screwworm cases, USDA secretary says

1 month ago

Weight loss drug maker sinks 23% after new safety data spooks investors

1 month ago